Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment-Reference-Cited by-同舟云学术

Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment

Published:2022-04-21 Issue:5 Volume:6 Page:301-308
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Kaneko Shun¹^ORCID,Tsuchiya Kaoru¹,Yasui Yutaka¹^ORCID,Tanaka Yuki¹,Inada Kento¹^ORCID,Ishido Shun¹,Kirino Sakura¹,Yamashita Koji¹,Hayakawa Yuka¹,Nobusawa Tsubasa¹,Matsumoto Hiroaki¹,Kakegawa Tatsuya¹,Higuchi Mayu¹,Takaura Kenta¹,Tanaka Shohei¹,Maeyashiki Chiaki¹,Tamaki Nobuharu¹^ORCID,Takahashi Yuka¹,Nakanishi Hiroyuki¹,Irie Takumi²,Ariizumi Shun‐Ichi³,Kurosaki Masayuki¹,Izumi Namiki¹

Affiliation:

1. Department of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan

2. Department of Surgery Musashino Red Cross Hospital Tokyo Japan

3. Department of Surgery, Institute of Gastroenterology Tokyo Women's Medical University Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12735